Despite overwhelming evidence of its devastating impact, war remains largely addressed as a political or humanitarian crisis, ...

Multiple healthcare organizations that have historically helped the CDC's Advisory Committee on Immunization Practices (ACIP) ...

For clinicians managing PTLDS, the CDC released a toolkit in 2024 and the American Medical Association launched a continuing ...

Could endocrine therapy plus a CDK4/6 inhibitor offer a viable chemo-sparing option in hormone receptor (HR)-positive/HER2-positive breast cancer?

Donanemab, approved by the FDA in 2024 to treat Alzheimer's disease, is a monoclonal antibody directed at N-terminally ...